Sign up to save your podcasts
Or
Share Health-Tech Innovations, Immunotherapy Breakthroughs, and Executive Compensation Analysis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Health-Tech Innovations, Immunotherapy Breakthroughs, and Executive Compensation Analysis
In this episode, we explore the latest innovations in health technology, including FitFast's AI-powered app for personalized fasting plans. We also discuss Oncolytics Biotech's promising immunotherapeutic agent, pelareorep, in the fight against metastatic breast cancer. Additionally, we delve into the impact of the 340B Drug Pricing Program on executive compensation in covered entities, as highlighted in a recent report by ADAP Advocacy. Lastly, we share details about the Clean Beauty Awards' 10th anniversary celebration and the call for brand entries for 2025.
View all episodes
In this episode, we explore the latest innovations in health technology, including FitFast's AI-powered app for personalized fasting plans. We also discuss Oncolytics Biotech's promising immunotherapeutic agent, pelareorep, in the fight against metastatic breast cancer. Additionally, we delve into the impact of the 340B Drug Pricing Program on executive compensation in covered entities, as highlighted in a recent report by ADAP Advocacy. Lastly, we share details about the Clean Beauty Awards' 10th anniversary celebration and the call for brand entries for 2025.